{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:13Z","timestamp":1790187193826,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.juro.2014.03.109","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T14:16:53Z","timestamp":1396448213000},"page":"843-849","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy and Safety of Polyacrylamide Hydrogel for the Treatment of Female Stress Incontinence: A Randomized, Prospective, Multicenter North American Study"],"prefix":"10.1097","volume":"192","author":[{"given":"Eric R.","family":"Sokol","sequence":"first","affiliation":[{"name":"Departments of Obstetrics and Gynecology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickey M.","family":"Karram","sequence":"additional","affiliation":[{"name":"The Christ Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dmochowski","sequence":"additional","affiliation":[{"name":"Department of Urology, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2014.03.109_bib1","unstructured":"Milsom I, Altman D, Lapitan MC et\u00a0al: Committee 1: Epidemiology of Urinary (UI) and Faecal (FI) Incontinence and Pelvic Organ Prolapse. International Continence Society. Available at http:\/\/www.ics.org\/publications\/ici_4\/files-book\/comite-1.pdf. Accessed March 27, 2014."},{"key":"10.1016\/j.juro.2014.03.109_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11934-011-0206-0","article-title":"Epidemiology of stress urinary incontinence in women","volume":"12","author":"Reynolds","year":"2011","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2014.03.109_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00192-012-2011-9","article-title":"Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents","volume":"24","author":"Davis","year":"2013","journal-title":"Int Urogynecol J"},{"issue":"suppl.","key":"10.1016\/j.juro.2014.03.109_bib4","first-page":"S68","article-title":"Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig","volume":"34","author":"Christensen","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.juro.2014.03.109_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1464-410X.2006.06205.x","article-title":"A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women","volume":"98","author":"Lose","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2014.03.109_bib6","article-title":"Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence","author":"Mouritsen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.juro.2014.03.109_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00192-010-1214-1","article-title":"An open multicenter study of polyacrylamide hydrogel (Bulkamid\u00ae) for female stress and mixed urinary incontinence","volume":"21","author":"Lose","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.juro.2014.03.109_bib8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00192-012-1761-8","article-title":"Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid\u00ae) for female stress and stress-predominant mixed incontinence","volume":"23","author":"Toozs-Hobson","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.juro.2014.03.109_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00404-013-2718-y","article-title":"Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety","volume":"288","author":"Maggiore","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.juro.2014.03.109_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00192-012-1834-8","article-title":"Bulking agents: an analysis of 500 cases and review of the literature","volume":"24","author":"Mohr","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.juro.2014.03.109_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT Statement. CONSORT Group","volume":"295","author":"Piaggio","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2014.03.109_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1067\/mob.2003.375","article-title":"Relationship between patient report and physician assessment of urinary incontinence severity","volume":"189","author":"Melville","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.juro.2014.03.109_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/AOG.0b013e3182161953","article-title":"Foreign-body granuloma after injection of calcium hydroxylapatite for type III stress urinary incontinence","volume":"118","author":"Gafni-Kane","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.juro.2014.03.109_bib14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00192-005-0038-x","article-title":"Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence","volume":"17","author":"Palma","year":"2006","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.juro.2014.03.109_bib15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0022-5347(01)67398-1","article-title":"Particulate silicone for use in periurethral injections: local tissue effects and search for migration","volume":"153","author":"Henly","year":"1995","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2014.03.109_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1368-504X.2005.00287.x","article-title":"Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass","volume":"59","author":"Kulkarni","year":"2005","journal-title":"Int J Clin Practise"},{"key":"10.1016\/j.juro.2014.03.109_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0302-2838(03)00374-9","article-title":"Systematic review: efficacy of silicone microimplants (Macroplastique\u00ae) therapy for stress urinary incontinence in adult women","volume":"44","author":"Ter Meulen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2014.03.109_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/gyn.2007.B-02281-1","article-title":"Late complications following Macroplastique\u00ae implantation for urodynamic stress incontinence","volume":"23","author":"Sagili","year":"2007","journal-title":"J Gynecol Surg"},{"key":"10.1016\/j.juro.2014.03.109_bib19","first-page":"1350","article-title":"Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence","volume":"166","author":"Pannek","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2014.03.109_bib20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0022-5347(05)00679-8","article-title":"Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence","volume":"175","author":"Madjar","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.03.109_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.eururo.2005.06.012","article-title":"Stress incontinence injection therapy: what is best for\u00a0our patients?","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471403211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471403211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2014.03.109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:33:18Z","timestamp":1651203198000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2014.03.109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1016\/j.juro.2014.03.109"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2014.03.109","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}